Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. (2016)
Attributed to:
Study into the potentially therapeutic immunomodulatory effects of gp120 in autoimmune rheumatic disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13075-016-1188-6
PubMed Identifier: 27993172
Publication URI: http://europepmc.org/abstract/MED/27993172
Type: Journal Article/Review
Volume: 18
Parent Publication: Arthritis research & therapy
Issue: 1
ISSN: 1478-6354